Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without Cataplexy

Sponsor
Harmony Biosciences, LLC (Industry)
Overall Status
No longer available
CT.gov ID
NCT03433131
Collaborator
(none)
71

Study Details

Study Description

Brief Summary

This EAP will be open to provide access to treatment with pitolisant while a U.S. New Drug Application (NDA) is being prepared and submitted for review for marketing approval. This program will be open to adult patients in the U.S. with Excessive Daytime Sleepiness (EDS) associated with narcolepsy, with or without cataplexy. Pitolisant will be made available through treating physicians participating in the program.

Condition or Disease Intervention/Treatment Phase

Study Design

Study Type:
Expanded Access
Official Title:
An Open Label Expanded Access Program Intended to Provide Treatment With HBS-101 (Pitolisant) to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without Cataplexy

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    1. In the opinion of the treating physician, the patient is capable of understanding and complying with protocol and program requirements, oral drug administration and care instructions.

    2. The patient or, when applicable, the patient's legally acceptable representative, signs and dates a written, ICF and any required privacy authorization prior to the initiation of any program procedures.

    3. Men or women, 18 years of age and over.

    4. Patients with a diagnosis of narcolepsy with or without cataplexy according to the ICSD or DSM criteria at the time of diagnosis.

    5. Patients should be free of prohibited treatments or have discontinued them for at least 7 days prior to the start of treatments.

    6. Women of child-bearing potential must have a negative serum pregnancy test performed at the screening visit.

    7. Due to the effectiveness of hormonal contraceptives potentially being reduced when used with pitolisant, alternative or concomitant barrier methods of contraception are required for patients taking hormonal contraceptives (e.g., ethinyl estradiol) when taking pitolisant and for at least 21 days after discontinuation of pitolisant treatment.

    Exclusion Criteria:
    1. The patient has severe hepatic impairment (Child-Pugh C).

    2. The patient is a woman who is breastfeeding or plans to breastfeed during their participation.

    3. The patient has, in the judgment of the treating physician, a history or current medical condition that could affect safety or poses an additional risk to the patient by their participation in the program.

    4. The patient is at high risk for suicide defined as a suicide attempt within the past year, significant risk determined by the investigator interview, or use of the Columbia Suicide Severity Rating Scale (C-SSRS).

    5. The patient has a history of hypersensitivity or allergic reaction to pitolisant or any inactive ingredient of the formulation.

    6. Current or recent (within one year) history of a substance abuse or dependence disorder including alcohol abuse as defined in Diagnostic and Statistical Manual of Mental Disorders (DSM-V).

    7. Patients with a known history of long QTc syndrome (e.g. syncope or arrhythmia) or any significant history of a serious abnormality of the ECG (e.g. recent myocardial infarction), or QTc Fridericia higher than 450 ms for male and 470 ms for female (electrocardiogram Fridericia's corrected QT interval = QT / 3√ RR).

    8. Significant abnormality in the physical examination or clinical laboratory results.

    9. Prior severe adverse reactions to CNS stimulants.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Sleep Disorders Center of Alabama Birmingham Alabama United States 35213
    2 CPC Cullman Alabama United States 35058
    3 Xenoscience Phoenix Arizona United States 85004-1150
    4 Xenoscience Phoenix Arizona United States 85004
    5 Foothills Neurology Phoenix Arizona United States 85048
    6 Mayo Clinic Scottsdale Arizona United States 85259
    7 Sleep Medicine Specialists of California San Ramon California United States 94583
    8 Santa Monica Sleep Disorders Center Santa Monica California United States 90404
    9 Children's Hospital Colorado Aurora Colorado United States 80045
    10 Colorado Sleep Institute Boulder Colorado United States 80301
    11 Norwalk Hospital Sleep Disorders Center Norwalk Connecticut United States 06850
    12 Clinical Neurosciences fo Tampa Bay Clearwater Florida United States 33756
    13 Mayo Clinic Jacksonville Florida United States 32224
    14 Sleep Medicine Specialists of South Florida, PA Miami Florida United States 33126
    15 Child Lung, Asthma Sleep Specialists Winter Park Florida United States 32789
    16 Emory University Atlanta Georgia United States 30329
    17 NeuroTrials Research Center Atlanta Georgia United States 30342
    18 The Neurological Center of North Georgia Gainesville Georgia United States 30501
    19 Critical Healthcare Decisions Savannah Georgia United States 31419
    20 Northwestern Medical Group Chicago Illinois United States 60611
    21 Rush University Medical Center Chicago Illinois United States 60637
    22 NorthShore Uni HealthSys-Glenbrook Hospital Glenview Illinois United States 60026
    23 Northshore Sleep Medicine Northbrook Illinois United States 60062
    24 Indiana Internal Medicine Consultants Greenwood Indiana United States 46143
    25 The University of Kansas Health System Fairway Kansas United States 66205
    26 Norton Pulmonary Specialists Louisville Kentucky United States 40218
    27 Maine Medical Partners - Neurology Scarborough Maine United States 04074
    28 The Center for Sleep and Wake Disorders Chevy Chase Maryland United States 20815
    29 Boston Children's Hospital Boston Massachusetts United States 02115
    30 The University of Michigan Ann Arbor Michigan United States 48109
    31 Henry Ford Health System Novi Michigan United States 48377
    32 Bronson Sleep Health Portage Michigan United States 49024
    33 Alliance Health Shelby Family Medicine Shelby Michigan United States 48317
    34 Fairview Health Services Brooklyn Park Minnesota United States 55443
    35 Mayo Clinic Rochester Minnesota United States 55905
    36 St. Lukes Hospital, Sleep Medicine Chesterfield Missouri United States 63017
    37 University of Missouri Columbia Missouri United States 65212
    38 Saint Luke's Hospital of Kansas City Kansas City Missouri United States 64111
    39 Montefiore Medical Center Bronx New York United States 10467
    40 Norwell Health New Hyde Park New York United States 11042
    41 NYU-FGP Comphrenhensive Epilepsy Center-Sleep Center New York New York United States 10016
    42 Columbia University New York New York United States 10032
    43 Unity Sleep Disorders Center Rochester New York United States 14618
    44 University of Rochester Sleep Center Rochester New York United States 35058
    45 Duke University Medical Center Durham North Carolina United States 27710
    46 Excel Psychiatric Associates, PA Huntersville North Carolina United States 28078
    47 Raleigh Neurology Assoc., PA Raleigh North Carolina United States 27607
    48 Neurology & Neuroscience Associates, Inc. Akron Ohio United States 44320
    49 Intrepid Research, LLC Cincinnati Ohio United States 45245
    50 Cleveland Clinic Cleveland Ohio United States 44195
    51 Ohio Sleep Medicine Institute Dublin Ohio United States 43017
    52 Oklahoma Heart Institute Tulsa Oklahoma United States 74104
    53 Oklahoma Heart Institute Tulsa Oklahoma United States 74133
    54 Legacy Medical Group Sleep Medicine Portland Oregon United States 97210
    55 Collegeville Family Practice Berwyn Pennsylvania United States 19426
    56 Paoli Sleep Center Paoli Pennsylvania United States 19301
    57 Thomas Jefferson University Philadelphia Pennsylvania United States 19107
    58 Maria J. Sunseri, MD, LLC Pittsburgh Pennsylvania United States 15224
    59 Abington Neurological Associates Willow Grove Pennsylvania United States 19090
    60 Respitory Specialists Wyomissing Pennsylvania United States 19610
    61 Brown Medicine/Rhode Island Hospital West Warwick Rhode Island United States 02893
    62 Bogan Sleep Consultants Columbia South Carolina United States 29201
    63 Sleep Medicine Associates of Texas Dallas Texas United States 75231
    64 Houston Neurology & Sleep Center Houston Texas United States 77063
    65 Sleep Therapy & Research Center San Antonio Texas United States 78229
    66 Comprehensive Sleep Medicine Associates Sugar Land Texas United States 77478
    67 Chalottesville Neurology and Sleep Medicine Charlottesville Virginia United States 22911
    68 Children's Hospital of The King's Daughters Norfolk Virginia United States 23507
    69 Eastern Virginia Medical School Norfolk Virginia United States 23507
    70 Stultz Sleep and Behavioral Health Barboursville West Virginia United States 25504
    71 Medical College of Wisonsin Milwaukee Wisconsin United States 53226

    Sponsors and Collaborators

    • Harmony Biosciences, LLC

    Investigators

    • Principal Investigator: Michael Thorpy, MD, Albert Einstein College of Medicine

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Harmony Biosciences, LLC
    ClinicalTrials.gov Identifier:
    NCT03433131
    Other Study ID Numbers:
    • HBS-101-CL-001
    First Posted:
    Feb 14, 2018
    Last Update Posted:
    Aug 28, 2019
    Last Verified:
    Aug 1, 2019

    Study Results

    No Results Posted as of Aug 28, 2019